NCT05406193

Brief Summary

Patients with complex multimorbidity experience a high treatment burden, fragmentation of care and poor clinical outcomes. General practice is the key organizational setting in terms of offering these patients integrated, longitudinal, and patient-centered care. Therefore, we propose a new general practice based model to improve overview, patient involvement and integration of care. The new care model consist of a teaching session on multimorbidity for the health care professionals, a prolonged overview consultation for patients with complex multimorbidity with the general practitioner, resulting in an individual care plan shared with the municipalities and secondary care, access to cross-sectoral video conferences with secondary care specialists and. Control practices provide health care as usual. We evaluate the care model in a cluster-randomized non-blinded, parallel-group trial in general practice. Fourteen general practices are allocated 1:1 to either intervention or control. We evaluate the effectiveness of the intervention with patient-reported questionnaire at baseline, 6-month follow-up, and 12-month follow-up. Primary outcome measure is the Patient Assessment of Chronic Illness Care (PACIC). Secondary outcome measure includes patient-reported quality of life and the treatment burden for the patients with multimorbidity. Furthermore, the project include a process evaluation of the complex intervention with the objective to assess how the intervention is delivered and to identify important facilitators and barriers for implementing the intervention. The new model is integrated into the existing health care system structures and has the potential for a sustainable improvement in care for patients with complex multimorbidity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

11 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 6, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

May 30, 2023

Status Verified

May 1, 2023

Enrollment Period

1.4 years

First QC Date

May 24, 2022

Last Update Submit

May 25, 2023

Conditions

Keywords

General practiceIntegrated careMultimorbidity

Outcome Measures

Primary Outcomes (1)

  • Change from baseline Patient Assessment of Chronic Illness Care (PACIC) at 12 months

    PACIC is a 20-item patient report instrument that assesses patient's receipt of clinical services and actions. Each item was scored on a 5-point scale ranging from 1 (no or never) to 5 (yes or always). Respondents rate how often they experienced the content described in each item. The scale range from 1-5 and is scored by averaging of items completed within that scale, and the overall PACIC is scored by averaging scores across all 20 items. Higher scores indicate higher patient assessment delivery of high-quality care for patients with chronic diseases.

    From baseline to 12-month follow-up

Secondary Outcomes (5)

  • Change from baseline Patient Assessment of Chronic Illness Care (PACIC) at 6 months

    From baseline to 6-month follow-up

  • Change from baseline EuroQol-5 Domain (EQ-5D-5L) at 6 months

    From baseline to 6-month follow-up

  • Change from baseline EuroQol-5 Domain (EQ-5D-5L) at 12 months

    From baseline to 12-month follow-up

  • Change from baseline Multimorbidity Treatment Burden Questionnaire (MTBQ) at 6 months

    From baseline to 6-month follow-up

  • Change from baseline Multimorbidity Treatment Burden Questionnaire (MTBQ) at 12 months

    From baseline to 12-month follow-up

Study Arms (2)

Intervention (CIM2)

EXPERIMENTAL

An extended overview consultation, lasting 45 minutes, with the general practitioner, the patient (and maybe a relative), and the care coordinator. An individual care plan is developed, covering planned activities in the three sectors (general practice, municipality, and hospital) that will take place within the 12-month intervention period. General practice coordinates the planned patient care between general practice, the municipality, and the hospital, and follow-up on the execution of planned healthcare activities. The individual care plan is shared electronically with the healthcare center in the municipality and with the outpatient clinics using the standard IT-communication tool provided by MedCom and a routinely used national standard in general practice, hospitals, and municipalities.

Other: Patient-centred complex intervention in complicated multimorbidity (CIM2)

Usual care

NO INTERVENTION

Patients with a general practitioner allocated to the control group will receive usual care.

Interventions

CIM2 is the second version of the Patient-centred complex intervention in complicated multimorbidity

Intervention (CIM2)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Has more than one of the 3 common chronic diseases (diabetes, chronic obstructive pulmonary, chronic heart conditions)
  • Has been hospitalised, or visited an outpatient clinic due to their chronic diseases during the previous year
  • Take at least five different prescription drugs assessed from the Shared Medicine Card recording in the general practice
  • The general practitioner or the nurse in the practice recognise the patient as a "demanding" patient with complicated multimorbidity that will benefit from an overview consultation.

You may not qualify if:

  • Patients who cannot speak Danish,
  • Patients who cannot give informed consent,
  • Patients who have a life expectancy of less than 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Lægerne Kanaltorvet

Albertslund, 2620, Denmark

ACTIVE NOT RECRUITING

Thorkil Christensen

Albertslund, 2620, Denmark

ACTIVE NOT RECRUITING

Brøndbyøster Torv

Brøndby, 2605, Denmark

ACTIVE NOT RECRUITING

Lægerne i Brohuset

Ishøj, 2635, Denmark

ACTIVE NOT RECRUITING

Lægecenter Korsør

Korsør, 4220, Denmark

ACTIVE NOT RECRUITING

Læge Depenau vej-Hansen

Slagelse, 4200, Denmark

ACTIVE NOT RECRUITING

Læge Jørgen Larsen

Slagelse, 4200, Denmark

WITHDRAWN

Læge Lene Stiggaard

Slagelse, 4200, Denmark

RECRUITING

Lægerne Reventlow, Wolfhagen og Bendtsen

Slagelse, 4200, Denmark

RECRUITING

Lægerne ved Lystskoven

Slagelse, 4200, Denmark

ACTIVE NOT RECRUITING

Lægerne Vallensbæk Nord

Vallensbæk, 2625, Denmark

ACTIVE NOT RECRUITING

Related Publications (1)

  • Lundstrom SL, Kamstrup-Larsen N, Barrett BA, Jorgensen LMB, Hansen SS, Andersen JS, Friderichsen B, Stockmarr A, Frolich A. A patient-centred care model for patients with complicated multimorbidity: Protocol for a pilot cluster randomised trial in general practice, municipalities, and hospitals. PLoS One. 2024 Dec 4;19(12):e0310697. doi: 10.1371/journal.pone.0310697. eCollection 2024.

Study Officials

  • Anne Frølich, Professor

    Innovation and Research Centre for Multimorbidity, Slagelse hospital, Region Zealand

    STUDY CHAIR

Central Study Contacts

Anne Frølich, Professor

CONTACT

Sanne L Lundstrøm, Senior Researcher

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2022

First Posted

June 6, 2022

Study Start

November 1, 2022

Primary Completion

April 1, 2024

Study Completion

May 1, 2024

Last Updated

May 30, 2023

Record last verified: 2023-05

Locations